Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

DiNardo, Courtney D., Hochhaus, Andreas, Frattini, Mark G., Yee, Karen, Zander, Thomas, Kraemer, Alwin, Chen, Xueying, Ji, Yan, Parikh, Nehal S., Choi, Joanne and Wei, Andrew H. (2023). A phase 1 study of IDH305 in patients with IDH1(R132)-mutant acute myeloid leukemia or myelodysplastic syndrome. J. Cancer Res. Clin. Oncol., 149 (3). S. 1145 - 1159. NEW YORK: SPRINGER. ISSN 1432-1335

Hyman, David M., Tran, Ben, Paz-Ares, Luis, Machiels, Jean-Pascal, Schellens, Jan H., Bedard, Philippe L., Campone, Mario, Cassier, Philippe A., Sarantopoulos, John, Vaishampayan, Ulka, Chugh, Rashmi, Mahipal, Amit, Lockhart, A. Craig, Sessa, Cristiana, Zander, Thomas, Ng, Matthew, Curigliano, Giuseppe ORCID: 0000-0003-1781-2518, Bendiske, Jennifer, Chen, Xueying, Choudhury, Somesh, Graus-Porta, Diana, Lewis, Nancy, Perez Garcia, Jose Manuel and Jose de Miguel-Luken, Maria (2019). Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations. JCO Precis. Oncol., 3. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 2473-4284

Nogova, Lucia, Sequist, Lecia V., Garcia, Jose Manuel Perez, Andre, Fabrice, Delord, Jean-Pierre, Hidalgo, Manuel, Schellens, Jan H. M., Cassier, Philippe A., Camidge, D. Ross, Schuler, Martin, Vaishampayan, Ulka ORCID: 0000-0001-5800-4571, Burris, Howard, Tian, G. Gary, Campone, Mario, Wainberg, Zev A., Lim, Wan-Teck ORCID: 0000-0002-4655-0206, LoRusso, Patricia, Shapiro, Geoffrey I., Parker, Katie, Chen, Xueying, Choudhury, Somesh, Ringeisen, Francois, Graus-Porta, Diana, Porter, Dale, Isaacs, Randi, Buettner, Reinhard and Wolf, Juergen (2017). Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study. J. Clin. Oncol., 35 (2). S. 157 - 176. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Pal, Sumanta K., Rosenberg, Jonathan E., Hoffman-Censits, Jean H., Berger, Raanan, Quinn, David I., Galsky, Matthew D., Wolf, Juergen, Dittrich, Christian, Keam, Bhumsuk, Delord, Jean-Pierre, Schellens, Jan H. M., Gravis, Gwenaelle, Medioni, Jacques, Maroto, Pablo, Sriuranpong, Virote, Charoentum, Chaiyut, Burris, Howard A., Grunwald, Viktor, Petrylak, Daniel, Vaishampayan, Ulka ORCID: 0000-0001-5800-4571, Gez, Eliahu, De Giorgi, Ugo, Lee, Jae-Lyun, Voortman, Jens, Gupta, Sumati, Sharma, Sunil, Mortazavi, Amir, Vaughn, David J., Isaacs, Randi, Parker, Katie, Chen, Xueying, Yu, Kun, Porter, Dale, Porta, Diana Graus and Bajorin, Dean F. (2018). Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations. Cancer Discov., 8 (7). S. 812 - 822. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 2159-8290

Pal, Sumanta K., Rosenberg, Jonathan E., Keam, Bhumsuk, Wolf, Juergen, Berger, Raanan, Dittrich, Christian, Hoffman-Censits, Jean H., Quinn, David ORCID: 0000-0002-1411-0417, van der Noll, Ruud, Burris, Howard A., Galsky, Matt D., Gravis, Gwenaelle, Lee, Jae-Lyun, Medioni, Jacques, Mortazavi, Amir, Maroto, Pablo, Parker, Katie, Chen, Xueying, Isaacs, Randi and Bajorin, Dean F. (2016). Efficacy of BGJ398, a fibroblast growth factor receptor (FGFR) 1-3 inhibitor, in patients (pts) with previously treated advanced/metastatic urothelial carcinoma (mUC) with FGFR3 alterations. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Fri Mar 29 11:45:07 2024 CET.